Ryght AI and Biorasi Partner to Enhance Clinical Trial Feasibility with AI

What's Happening?

Ryght AI has partnered with Biorasi, a global clinical research organization, to deliver AI-powered feasibility solutions for biotech and biopharma sponsors. The collaboration aims to improve site selection and study startup through AI digital twins of research sites, addressing industry challenges such as inaccurate site selection and prolonged feasibility timelines.

Why It's Important?

The partnership between Ryght AI and Biorasi represents a significant advancement in clinical trial management, leveraging AI technology to enhance efficiency and accuracy. The collaboration could lead to faster study startups and reduced trial delays, benefiting biotech and biopharma sponsors. It highlights the growing role of AI in transforming healthcare and research industries.